Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Alberta

$25,000.00

The role of novel red yeast rice formulation to modulate lipid metabolism as a natural health product

EF 2010-11

Résumé
The primary objective of this 6 month 'engagement' study is to utilize a novel animal model with high blood lipids to assess the potential lipid lowering efficacy of red yeast formulations developed by SinoVeda Canada Inc. The intestine is the first-pass organ for the metabolism of dietary lipids and has an important role in whole body cholesterol homeostasis. While the intestine is known predominantly to absorb and secrete cholesterol and contributes to faecal sterol removal, it has also been proposed to contribute to the regulation of plasma cholesterol concentration. Funding from my NSERC Discovery grant, has revealed that the intestine can modulate it's secretion of cholesterol and triglyceride (TG) under different metabolic and dietary fatty-acid conditions. The purpose of this new Engage application is to utilize the expertise that my group has developed to partner with a provincial company to exploit this new knowledge to develop a new Natural Health Product (NHP). The funds from the Engage program will enable my academic research group to develop a pilot project with SinoVeda Inc. that will yield a larger opportunity for new NHPs for cholesterol lowering.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
401997-2010
Name nom
Proctor, Spencer
Department département
Agricultural, Food and Nutritional Science
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2010
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
6407
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Nutrition
Research subject fr
Nutrition
Partie
1
Nb partie
1
Application title
The role of novel red yeast rice formulation to modulate lipid metabolism as a natural health product
Keyword
NSERC
Application summary
The primary objective of this 6 month 'engagement' study is to utilize a novel animal model with high blood lipids to assess the potential lipid lowering efficacy of red yeast formulations developed by SinoVeda Canada Inc. The intestine is the first-pass organ for the metabolism of dietary lipids and has an important role in whole body cholesterol homeostasis. While the intestine is known predominantly to absorb and secrete cholesterol and contributes to faecal sterol removal, it has also been proposed to contribute to the regulation of plasma cholesterol concentration. Funding from my NSERC Discovery grant, has revealed that the intestine can modulate it's secretion of cholesterol and triglyceride (TG) under different metabolic and dietary fatty-acid conditions. The purpose of this new Engage application is to utilize the expertise that my group has developed to partner with a provincial company to exploit this new knowledge to develop a new Natural Health Product (NHP). The funds from the Engage program will enable my academic research group to develop a pilot project with SinoVeda Inc. that will yield a larger opportunity for new NHPs for cholesterol lowering.